In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

Silo Pharma, Inc. announced positive preclinical results for its novel extended-release ketamine implant, SP-26, targeting fibromyalgia treatment. The study demonstrated strong tolerability, safety, ...

Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release ...

Please provide your email address to receive an email when new articles are posted on . The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as sustained-release drug delivery systems as they can encapsulate various ...